Matti Nykter

Tampere University - Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tays Cancer Centre

SCHOLARLY PAPERS

2

DOWNLOADS

29

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Enhancer Profiling Identifies Epigenetic Markers of Endocrine Resistance and Reveals Therapeutic Options for Metastatic Castration-Resistant Prostate Cancer Patients

Number of pages: 88 Posted: 13 Mar 2023
Netherlands Cancer Institute - Division of Oncogenomics, Netherlands Cancer Institute - Division of Oncogenomics, Netherlands Cancer Institute - Division of Oncogenomics, Netherlands Cancer Institute - Division of Oncogenomics, University of Washington - Department of Urology, University of Washington - Department of Urology, Tampere University - Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tays Cancer Centre, VU University Amsterdam - Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Netherlands Cancer Institute - Division of Oncogenomics, Netherlands Cancer Institute - Division of Oncogenomics, Netherlands Cancer Institute - Division of Oncogenomics, Netherlands Cancer Institute - Division of Molecular Carcinogenesis, Netherlands Cancer Institute - Division of Molecular Carcinogenesis, Tampere University - Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tays Cancer Centre, Netherlands Cancer Institute - Department of Biometrics, Netherlands Cancer Institute - Department of Pathology, Netherlands Cancer Institute - Division of Molecular Carcinogenesis, Erasmus University Rotterdam (EUR) - Department of Urology, Erasmus University Rotterdam (EUR) - Department of Pathology, Cancer Institute, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Netherlands Cancer Institute - Division of Molecular Carcinogenesis, Tampere University - Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tays Cancer Centre, Netherlands Cancer Institute - Division of Molecular Carcinogenesis, University of Washington - Department of Urology, Netherlands Cancer Institute - Division of Oncogenomics and Netherlands Cancer Institute - Division of Oncogenomics
Downloads 21 (1,150,978)

Abstract:

Loading...

mCRPC, enzalutamide, epigenetics, androgen receptor, H3K27ac, HDAC inhibitors, biomarkers, hormone intervention

2.

Constrained Hypermutation and Absence of TERT Promoter Mutations in Lynch Syndrome-Associated Urothelial Cancer

Number of pages: 20 Posted: 04 Apr 2025
Tampere University, Tampere University, Tampere University, Hospital Nova of Central Finland, Hospital Nova of Central Finland, Wellbeing Services County of Central Finland, Tampere University, Tampere University, Tampere University - Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tays Cancer Centre, Tampere University - Tampere University Hospital, Wellbeing Services County of Central Finland, Tampere University, Tampere University and Independent
Downloads 8 (1,296,582)

Abstract:

Loading...

Lynch syndrome, urothelial cancer, DNA mismatch repair, Hypermutation, Telomerase